Wei Wei

9PUBLICATIONS
57CO-AUTHORS
Stochastic analysis and modellingPlanning and decision makingGene and molecular therapyMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 11, 2025
Statistical considerations for evaluating treatment effect under various non-proportional hazard scenarios.

Xinyu Zhang, Erich J Greene, Ondrej Blaha

|Jun 26, 2024
Propensity score weighted multi-source exchangeability models for incorporating external control data in randomized clinical trials.

Wei Wei, Yunxuan Zhang, Satrajit Roychoudhury

|Apr 10, 2024
A Bayesian platform trial design with hybrid control based on multisource exchangeability modelling.

Wei Wei, Ondrej Blaha, Denise Esserman

|Aug 03, 2023
A Phase II Trial of the CD40 Agonistic Antibody Sotigalimab (APX005M) in Combination with Nivolumab in Subjects with Metastatic Melanoma with Confirmed Disease Progression on Anti-PD-1 Therapy.

Sarah A Weiss, Mario Sznol, Montaser Shaheen

|Jun 30, 2023
Quantitative DNA Repair Biomarkers and Immune Profiling for Temozolomide and Olaparib in Metastatic Colorectal Cancer.

Michael Cecchini, Janie Y Zhang, Wei Wei

|Jun 28, 2023
NCI 7977: A Phase I Dose-Escalation Study of Intermittent Oral ABT-888 (Veliparib) plus Intravenous Irinotecan Administered in Patients with Advanced Solid Tumors.

Michael Cecchini, Zenta Walther, Wei Wei

Pageof 2

Frequent Collaborators

3 joint publications

Denise Esserman

2 joint publications

Patricia LoRusso

2 joint publications

Kurt A Schalper

2 joint publications

Ondrej Blaha